Bengani H et al. Clinical and molecular consequences of disease-associated de novo mutations in SATB2. Genet Med. 2017;19(8):900-908. PMID: 28151491
Zarate YA et al. Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2. Clin Genet. 2021;99(4):547-557. PMID: 33381861
Zarate YA et al. Mutation update for the SATB2 gene. Hum Mutat. 2019;40(8):1013-1029. PMID: 31021519
Zarate YA et al. Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome. Am J Med Genet A. 2018;176(4):925-935. PMID: 29436146
Zarate YA et al. SATB2-Associated Syndrome. in GeneReviews((R)), MP Adam et al. Editors. 2017;1993-2021: Seattle (WA). PMID: 29023086
Zarate YA and JL Fish. SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations. Am J Med Genet A. 2017;173(2):327-337. PMID: 27774744